about
Prevalence and risk of hypertension in renal disease--data from the Czech Registry of Renal Biopsies.The coincidence of IgA nephropathy and Fabry diseaseIncreased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis.Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-upCyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.IgA nephropathy in Czech patients--are we able reliably predict the outcome?Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters.Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease.Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil.Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011.Unusual manifestation of AL amyloidosis--stenosis of inferior vena cava.A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population.Silica and Asbestos Exposure in ANCA-Associated Vasculitis with Pulmonary InvolvementIncomplete distal renal tubular acidosis coinherited with a mutation in the band 3 (AE1) geneAcute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndromeGenetic analysis of Gitelman syndrome patients from the Czech Republic and Slovakia--three novel mutations foundTreatment of lupus nephritis with cyclosporine - an outcome analysisInfluence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney diseaseIntracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-upThe diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis
P50
Q31152864-D9A42D2E-A41D-4D90-B06C-FA089F1735BEQ34543669-0E7EFE66-25F4-4540-A0D5-A7490F1D412AQ35157297-B537D89F-50B6-45BE-8CCB-A76BC7345E9EQ36477390-50532F8F-883D-4992-BC55-FE8917524267Q38372154-1A38C412-5C8B-4C0A-BCD0-44B9AC485ED4Q41659582-8E4851F2-15D9-4AD0-9AB2-37189E25ACA1Q41667048-55565C05-FB12-4068-B783-1BE74DE36546Q43486705-E909D91C-4492-4416-BD8B-7F06253FEF9DQ44405312-8F35C2BA-DAF5-4BB3-81BA-D8EA9347646CQ45211267-00CE1E56-BBF8-4C5C-A5BD-50C266DCA51DQ46632424-B17AFDF9-EA59-4CDB-8C96-1E19A91E6200Q46982248-57ACB8EB-4C5D-476D-B2F5-4454A33AF57CQ48932587-640D7A64-ABF9-4158-AB4C-151E590B5CBEQ51245107-92D20879-4C7D-4357-A405-4451C96A8AF0Q51257563-E9BAF6BF-337F-44A2-8207-9880A7228874Q51780560-203FF97B-594B-491A-BE3A-AD2036AEE28DQ61040863-5B52681A-4C39-427C-859E-6BBD7F8BCD63Q73718882-319E50F1-67BB-48F3-9750-3F1248294CB2Q77484687-98DE0558-4971-466A-829D-50EA6D1E5AB9Q79422918-30CF6D09-DF7A-41A1-BAA5-613989DB2F99Q80065974-E116660F-FB82-49F2-8E94-29BA8206660DQ80193343-97970290-58E1-4CC2-8600-BD0640A1FAFBQ84240440-C3DC71BE-BE7F-4D3D-8E28-90E639C8519DQ85956725-2A55DE5E-2118-4EEF-BEEE-49973A1C40C3
P50
description
hulumtuese
@sq
lékařka
@cs
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Romana Rysava
@ast
Romana Rysava
@es
Romana Rysava
@nl
Romana Rysava
@sl
Romana Ryšavá
@cs
Romana Ryšavá
@en
type
label
Romana Rysava
@ast
Romana Rysava
@es
Romana Rysava
@nl
Romana Rysava
@sl
Romana Ryšavá
@cs
Romana Ryšavá
@en
altLabel
Romana Rysava
@en
prefLabel
Romana Rysava
@ast
Romana Rysava
@es
Romana Rysava
@nl
Romana Rysava
@sl
Romana Ryšavá
@cs
Romana Ryšavá
@en
P214
P1053
O-5942-2017
P106
P1153
6603913794
P19
P21
P214
P31
P3829
P496
0000-0002-4162-128X
P569
1967-01-01T00:00:00Z
P691
P735
P7859
viaf-85855997